Drugs / methoxypsoralen
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00056056 Background | Jan 2003 → May 2010 | lymphoma | European Organisation for Research and Treatment of Cancer - EORTC | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | methoxypsoralen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00056056 ↗ |
| Route | Oral | “Patients receive PUVA comprising oral methoxsalen given 2 hours before whole body ultraviolet A therapy.” NCT00056056 ↗ |